Cost-effectiveness of ticagrelor and generic clopidogrel in patients with acute coronary syndrome in Switzerland
QUESTION UNDER STUDY: The aim of this study was to evaluate the cost-effectiveness of ticagrelor and generic clopidogrel as add-on therapy to acetylsalicylic acid (ASA) in patients with acute coronary syndrome (ACS), from a Swiss perspective. METHODS: Based on the PLATelet inhibition...
Main Authors: | David Gasche, Tanja Ulle, Bernhard Meier, Roger-Axel Greiner |
---|---|
Format: | Article |
Language: | English |
Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2013-09-01
|
Series: | Swiss Medical Weekly |
Online Access: | https://www.smw.ch/index.php/smw/article/view/1748 |
Similar Items
-
Cost-Effectiveness Comparison between Ticagrelor and Clopidogrel in Acute Coronary Syndrome in Iran
by: Amir Hashemi-meshkini, et al.
Published: (2023-04-01) -
Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada
by: Grima DT, et al.
Published: (2014-01-01) -
Cost of acute coronary syndrome in Switzerland in 2008
by: Simon Wieser, et al.
Published: (2012-08-01) -
Ticagrelor versus clopidogrel in East Asian patients with acute coronary syndrome: A meta-analysis
by: He Meijiao, et al.
Published: (2022-02-01) -
Ticagrelor versus clopidogrel in the management of acute myocardial infarction
by: Candice Volney, et al.
Published: (2019-07-01)